Relationship between maternal c-reactive protein level and neonatal outcome in patients with preterm premature rupture of membranes treated with Ampicillin and Azithromycin

References

• Bańkowska EM, Leibschang J, Pawłowska A. 2003. Usefulness of determination of granulocyte elastase plasma level, c-reactive protein and white blood cell count in prediction in intrauterine infection in pregnant women after PROM. Ginekologia Polska 74:1037–1043.
   PubMedGoogle Scholar
• Coksaygan T, Viscardi RM, Waites KB, Roberts VHJ, Novy MJ, Grigsby PL. 2010. Periventricular neuronal damage associated with ureaplasma intra amniotic infection is diminished by maternal azithromycin (AZI) treatment. Reproductive Sciences 17:178A.
   Web of Science ®Google Scholar
• Farb HF, Arnesen M, Geistler P, Knox GE. 1983. C-reactive protein with premature rupture of membranes and premature labor. Obstetrics and Gynecology 62:49–51.
   PubMed Web of Science ®Google Scholar
• Fisk NM, Fysh J, Child AG, Gatenby PA, Jeffery H, Bradfield AH. 1987. Is C-reactive protein really useful in preterm premature rupture of the membranes? British Journal of Obstetrics and Gynaecology 94:1159–1164.
   PubMedGoogle Scholar
• Fujiwara A, Fukushima K, Inoue H, Takashima T, Nakahara H, Satoh S, et al. 2014. Perinatal management of preterm premature ruptured membranes affects neonatal prognosis. Journal of Perinatal Medicine 42:499–505.
   PubMed Web of Science ®Google Scholar
• Goepfert AR, Andrews WW, Carlo W, Ramsey PS, Cliver SP, Goldenberg RL, et al. 2004. Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity. American Journal of Obstetrics and Gynecology 191:1375–1381.
   PubMed Web of Science ®Google Scholar
• Grigsby PL, Novy MJ, Sadowsky DW, Morgan TK, Long M, Acosta E, et al. 2012. Maternal azithromycin therapy for ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model. American Journal of Obstetrics and Gynecology 207:475.e1–475.e14.
   PubMed Web of Science ®Google Scholar
• Hawrylyshyn P, Bernstein P, Milligan JE, Soldin S, Pollard A, Papsin FR. 1983. Premature rupture of membranes: the role of C-reactive protein in the prediction of chorioamnionitis. American Journal of Obstetrics and Gynecology 147:240–246.
   PubMed Web of Science ®Google Scholar
• Hirsch W, Koppitz D, Morack G, Gerhardt C. 1989. C-reactive protein in the maternal serum and risk of fetal infection in premature rupture of the fetal membranes and threatened premature labor. Zentralbl Gynakol 111:1411–1416.
   PubMedGoogle Scholar
• Hofer N, Kothari R, Morris N, Müller W, Resch B. 2013. The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates. American Journal of Obstetrics and Gynecology 209:542.e1–542.e11.
   PubMed Web of Science ®Google Scholar
• Kurdoglu M, Kolusari A, Adali E, Yildizhan R, Kurdoglu Z, Kucukaydin Z, et al. 2010. Does residual amniotic fluid after preterm premature rupture of membranes have an effect on perinatal outcomes? 12 years experience of a tertiary care center. Archives of Gynecology and Obstetrics 281:601–607.
   PubMed Web of Science ®Google Scholar
• Kurki T, Teramo K, Ylikorkala O, Paavonen J. 1990. C-reactive protein in preterm premature rupture of the membranes. Archives of Gynecology and Obstetrics 247:31–37.
   PubMed Web of Science ®Google Scholar
• Lee SY, Park KH, Jeong EH, Oh KJ, Ryu A, Park KU. 2012. Relationship between maternal serum C-reactive protein, funisitis and early-onset neonatal sepsis. Journal of Korean Medical Science 27:674–680.
   PubMed Web of Science ®Google Scholar
• Lieman JM, Brumfield CG, Carlo W, Ramsey PS. 2005. Preterm premature rupture of membranes: is there an optimal gestational age for delivery? Obstetrics and Gynecology 105:12–17.
   PubMed Web of Science ®Google Scholar
• Lin SJ, Yan DC, Lee WI, Kuo ML, Hsiao HS, Lee PY. 2012. Effect of azithromycin on natural killer cell function. International Immunopharmacology 13:8–14.
   PubMed Web of Science ®Google Scholar
• Manimtim WM, Hasday JD, Hester L, Fairchild KD, Lovchik JC, Viscardi RM. 2001. Ureaplasma urealyticum modulates endotoxin-induced cytokine release by human monocytes derived from preterm and term newborns and adults. Infection and Immunity 69:3906–3915.
   PubMed Web of Science ®Google Scholar
• Mercer BM, Rabello YA, Thurnau GR, Miodovnik M, Goldenberg RL, Das AF, et al. 2006. NICHD-MFMU Network. The NICHD-MFMU antibiotic treatment of preterm PROM study: impact of initial amniotic fluid volume on pregnancy outcome. American Journal of Obstetrics and Gynecology 194:438–445.
   PubMed Web of Science ®Google Scholar
• Modena AB, Kaihura C, Fieni S. 2004. Prelabour rupture of the membranes: recent evidence. Acta Biomedica 75:5–10.
   PubMedGoogle Scholar
• Murtha AP, Sinclair T, Hauser ER, Swamy GK, Herbert WN, Heine RP. 2007. Maternal serum cytokines in preterm premature rupture of membranes. Obstetrics and Gynecology 109:121–127.
   PubMed Web of Science ®Google Scholar
• Neerhof MG, Cravello C, Haney EI, Silver RK. 1999. Timing of labor induction after premature rupture of membranes between 32 and 36 weeks' gestation. American Journal of Obstetrics and Gynecology 180:349–352.
   PubMed Web of Science ®Google Scholar
• Park JS, Yoon BH, Romero R, Moon JB, Oh SY, Kim JC, et al. 2001. The relationship between oligohydramnios and the onset of preterm labor in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology 184:459–462.
   PubMed Web of Science ®Google Scholar
• Pasquier JC, Bujold E, Rabilloud M, Picaud JC, Ecochard R, Claris O, et al. 2007. Effect of latency period after premature rupture of membranes on 2 years infant mortality (DOMINOS study). European Journal of Obstetrics Gynecology and Reproductive Biology 135:21–27.
   PubMed Web of Science ®Google Scholar
• Pepys MB, Hirschfield GM. 2003. C-reactive protein: a critical update. Journal of Clinical Investigation 111:1805–1812.
   PubMed Web of Science ®Google Scholar
• Polancec DS, Munic Kos V, Banjanac M, Vrancic M, Cuzic S, Belamaric D, et al. 2012. Azithromycin drives in vitro GM-CSF/IL-4-induced differentiation of human blood monocytes toward dendritic-like cells with regulatory properties. Journal of Leukocyte Biology 91:229–243.
   PubMed Web of Science ®Google Scholar
• Practice bulletins. 2013. No. 139: premature rupture of membranes. Obstetrics and Gynecology 122:918–930.
   PubMedGoogle Scholar
• Salzer HR, Genger H, Muhar U, Lischka A, Schatten C, Pollak A. 1987. C-reactive protein: an early marker for neonatal bacterial infection due to prolonged rupture of amniotic membranes and/or amnionitis. Acta Obstetricia et Gynecologica Scandinavica 66:365–367.
   PubMed Web of Science ®Google Scholar
• Sereepapong W, Limpongsanurak S, Triratanachat S, Wannakrairot P, Charuruks N, Krailadsiri P. 2001. The role of maternal serum C-reactive protein and white blood cell count in the prediction of chorioamnionitis in women with premature rupture of membranes. Journal of the Medical Association of Thailand 84:360–366.
   Google Scholar
• Skrablin S, Lovric H, Banovic V, Kralik S, Dijakovic A, Kalafatic D. 2007. Maternal plasma interleukin-6, interleukin-1beta and C-reactive protein as indicators of tocolysis failure and neonatal outcome after preterm delivery. Journal of Maternal Fetal and Neonatal Medicine 20:335–341.
   PubMed Web of Science ®Google Scholar
• Smith G, Rafuse C, Anand N, Brennan B, Connors G, Crane J, et al. 2005. Prevalence, management, and outcomes of preterm prelabour rupture of the membranes of women in Canada. Journal of Obstetrics Gynaecology Canada 27:547–553.
   PubMedGoogle Scholar
• Torbé A, Kowalski K. 2010. Maternal serum and vaginal fluid C-reactive protein levels do not predict early-onset neonatal infection in preterm premature rupture of membranes. Journal of Perinatology 30:655–659.
   PubMed Web of Science ®Google Scholar
• Trochez-Martinez RD, Smith P, Lamont RF. 2007. Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. British Journal of Obstetrics and Gynaecology 114:796–801.
   Google Scholar
• van der Ham DP, van der Heyden JL, Opmeer BC, Mulder AL, Moonen RM, van Beek JH, et al. 2012. Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial. American Journal of Obstetrics and Gynecology 207:276.e1–210.
   Web of Science ®Google Scholar
• van der Ham DP, Vijgen SM, Nijhuis JG, van Beek JJ, Opmeer BC, Mulder AL, PPROMEXIL trial group. et al. 2012; Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine 2012;9:e1001208.
   PubMed Web of Science ®Google Scholar
• van der Heyden JL, van Teeffelen SS, Coolen AC, Halbertsma FJ, Aardenburg R, Mertens HJ, et al. 2010. Is it useful to measure C-reactive protein and leukocytes in patients with prelabor rupture of membranes? American Journal of Perinatology 27:543–547.
   PubMed Web of Science ®Google Scholar
• Vermillion ST, Kooba AM, Soper DE. 2000. Amniotic fluid index values after preterm premature rupture of the membranes and subsequent perinatal infection. American Journal of Obstetrics and Gynecology 183:271–276.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Jun JK, Park KH, Syn HC, Gomez R, Romero R. 1996. Serum C-reactive protein, white blood cell count, and amniotic fluid white blood cell count in women with preterm premature rupture of membranes. Obstetrics and Gynecology 88:1034–1040.
   PubMed Web of Science ®Google Scholar